|
|
|
|
LEADER |
01000caa a22002652 4500 |
001 |
NLM153562633 |
003 |
DE-627 |
005 |
20250206052329.0 |
007 |
tu |
008 |
231223s2005 xx ||||| 00| ||chi c |
028 |
5 |
2 |
|a pubmed25n0512.xml
|
035 |
|
|
|a (DE-627)NLM153562633
|
035 |
|
|
|a (NLM)15698495
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a chi
|
100 |
1 |
|
|a Weng, Li-xin
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Protective effects of acidic fibroblast growth factor on intestinal ischemia/reperfusion in rats
|
264 |
|
1 |
|c 2005
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
500 |
|
|
|a Date Completed 06.10.2009
|
500 |
|
|
|a Date Revised 21.11.2013
|
500 |
|
|
|a published: Print
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a OBJECTIVE: To observe the change in hepatic and renal functions, change in the plasma D-lactate level, and the expression of proliferating cell nuclear antigen (PCNA) after intestinal I/R injury, so as to explore the effects of reconstructive human acid fibroblast growth factor(aFGF) on intestinal I/R injury in rats
|
520 |
|
|
|a METHODS: One hundred and twenty-six Wistar rats were divided into sham-operated, ischemia (45 minutes) plus reperfusion, reconstructive human aFGF treatment (2, 4, 8 microg aFGF) and wild type aFGF(2, 6, 12, and 24 hours, respectively) groups. Hepatic and renal functions and the levels of plasma D-lactate were determined and the expression of PCNA was assessed
|
520 |
|
|
|a RESULTS: Compared with all other groups, bowel barrier function and hepatic and renal functions showed most marked deterioration in sham-operated group. The damages were less marked in reconstructive human aFGF group compared with other groups 24 hours after ischemia/reperfusion of the intestine, and the protective effect was best shown when 4 microg of aFGF was given. The trend of expression of PCNA was similar to that of changes in D-lactate level
|
520 |
|
|
|a CONCLUSION: Wild type reconstructive human aFGF treatment significantly improves the outcome of ischemia/reperfusion injury to the intestine, and the effect is dose-dependent
|
650 |
|
4 |
|a English Abstract
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a Research Support, Non-U.S. Gov't
|
650 |
|
7 |
|a Proliferating Cell Nuclear Antigen
|2 NLM
|
650 |
|
7 |
|a Fibroblast Growth Factor 1
|2 NLM
|
650 |
|
7 |
|a 104781-85-3
|2 NLM
|
650 |
|
7 |
|a Lactic Acid
|2 NLM
|
650 |
|
7 |
|a 33X04XA5AT
|2 NLM
|
700 |
1 |
|
|a Fu, Xiao-bing
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Li, Xiu-xia
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Sun, Tong-zhu
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Zheng, Shu-yun
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Chen, Wei
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Li, Jun-you
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue
|d 1998
|g 17(2005), 2 vom: 08. Feb., Seite 98-101
|w (DE-627)NLM098227793
|x 1003-0603
|7 nnns
|
773 |
1 |
8 |
|g volume:17
|g year:2005
|g number:2
|g day:08
|g month:02
|g pages:98-101
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|d 17
|j 2005
|e 2
|b 08
|c 02
|h 98-101
|